These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7011655)

  • 1. Quality control of drug assays.
    Ayers G; Burnett D; Griffiths A; Richens A
    Clin Pharmacokinet; 1981; 6(2):106-17. PubMed ID: 7011655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of assay errors in drug measurements from the Heathcontrol interlaboratory quality assessment schemes.
    Wilson JF; Newcombe RG; Marshall RW; Williams J; Richens A
    Clin Chim Acta; 1984 Nov; 143(3):203-16. PubMed ID: 6499219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra- and interlaboratory sources of imprecision in drug measurements by different techniques.
    Tsanaclis LM; Wilson JF
    Clin Chem; 1993 May; 39(5):851-5. PubMed ID: 8485875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interlaboratory proficiency-testing programs: a computer model to assess their capability to correctly characterize intralaboratory performance.
    Ehrmeyer SS; Laessig RH
    Clin Chem; 1987 Jun; 33(6):784-7. PubMed ID: 3594814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The health and safety executive interlaboratory quality control scheme for isocyanates.
    Bagon DA
    Ann Occup Hyg; 1990 Feb; 34(1):77-83. PubMed ID: 2327691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interlaboratory variability in drug assay: a comparison of quality control data with reanalysis of routine patient samples. I: Anticonvulsant drugs and theophylline. Clinical Pharmacology and Toxicology Study Group, Italian Society for Clinical Biochemistry.
    Ther Drug Monit; 1991 Mar; 13(2):131-9. PubMed ID: 2053120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of the use of fixed limits to characterize intralaboratory performance by proficiency testing.
    Ehrmeyer SS; Laessig RH
    Clin Chem; 1987 Oct; 33(10):1901-2. PubMed ID: 3665047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model for the statistical description of analytical errors occurring in clinical chemical laboratories with time.
    Hyvärinen A
    Scand J Clin Lab Invest Suppl; 1985; 175():1-84. PubMed ID: 3858970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of techniques for measurement of therapeutic drugs in serum. A comparison based on external quality assessment data.
    Wilson JF; Tsanaclis LM; Perrett JE; Williams J; Wicks JF; Richens A
    Ther Drug Monit; 1992 Apr; 14(2):98-106. PubMed ID: 1585409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 1978 College of American Pathologists Therapeutic Drug Monitoring Interlaboratory Survey Program.
    Juel R
    Am J Clin Pathol; 1979 Aug; 72(2 Suppl):306-19. PubMed ID: 474507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The external quality assessment schemes in Thailand.
    Opartkiattikul N; Bejrachandra S
    Rinsho Byori; 2002 Feb; 50(2):121-5. PubMed ID: 11925846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An audit of therapeutic drug monitoring service provision by laboratories participating in an external quality assessment scheme.
    Thomson AH; Watson ID; Wilson JF; Sweeney G; Dawkins CE; Smith BL; Williams J; Capps NE; Toseland PA
    Ther Drug Monit; 1998 Jun; 20(3):248-52. PubMed ID: 9631919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interlaboratory quality control in gynecologic cytopathology using the novel CONQUISTADOR software. Interobserver reproducibility in the Latin American screening study.
    Alderisio M; Branca M; Erzen M; Longatto-Filho A; Derchain S; Tatti S; Vighi S; Roteli-Martins C; Leoncini L; Maeda MY; Montis D; Gontijo R; Sarian LO; Syrjänen K
    Acta Cytol; 2007; 51(6):872-81. PubMed ID: 18077979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Danish external quality assessment scheme.
    Christensen JM; Kristiansen J
    Ann Ist Super Sanita; 1996; 32(2):221-4. PubMed ID: 8913039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
    Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance goals for the laboratory testing of antithrombin, protein C and protein S.
    Meijer P; Haverkate F; Kluft C
    Thromb Haemost; 2006 Nov; 96(5):584-9. PubMed ID: 17080214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interlaboratory and intralaboratory variabilities in the Environmental Lead Proficiency Analytical Testing (ELPAT) Program.
    Schlecht PC; Song R; Groff JH; Feng HA; Esche CA
    Am Ind Hyg Assoc J; 1997 Nov; 58(11):779-86. PubMed ID: 9373923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interlaboratory variability in drug assay: a comparison of quality control data with reanalysis of routine patient samples. II: Digoxin. Clinical Pharmacology and Toxicology Study Group, Italian Society for Clinical Biochemistry.
    Ther Drug Monit; 1991 Mar; 13(2):140-5. PubMed ID: 2053121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scoring and performance of analysis and interpretation of toxicologic cases assessed by external quality assurance.
    Watson ID; Wilson JF; Toseland PA; Smith BL; Williams J; Capps NE; Thomson AH; Sweeney G; Sandle LN
    Ther Drug Monit; 2002 Feb; 24(1):156-8. PubMed ID: 11805737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trace elements in body fluids: external quality assessment scheme in The Netherlands.
    Weykamp CW; Penders TJ
    Ann Ist Super Sanita; 1996; 32(2):271-5. PubMed ID: 8913046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.